OPKO Health, Inc. (OPK)
1.61
+0.24
(+17.52%)
USD |
NASDAQ |
Oct 15, 16:00
1.65
+0.04
(+2.48%)
After-Hours: 07:32
OPKO Health Research and Development Expense (Quarterly) : 33.17M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.17M |
| March 31, 2026 | 29.20M |
| December 31, 2025 | 32.77M |
| September 30, 2025 | 30.08M |
| June 30, 2025 | 30.34M |
| March 31, 2025 | 30.84M |
| December 31, 2024 | 30.40M |
| September 30, 2024 | 28.77M |
| June 30, 2024 | 24.08M |
| March 31, 2024 | 21.94M |
| December 31, 2023 | 19.40M |
| September 30, 2023 | 19.44M |
| June 30, 2023 | 18.16M |
| March 31, 2023 | 32.60M |
| December 31, 2022 | 19.50M |
| September 30, 2022 | 18.79M |
| June 30, 2022 | 17.25M |
| March 31, 2022 | 18.31M |
| December 31, 2021 | 21.00M |
| September 30, 2021 | 18.31M |
| June 30, 2021 | 18.22M |
| March 31, 2021 | 19.32M |
| December 31, 2020 | 17.45M |
| September 30, 2020 | 18.49M |
| June 30, 2020 | 17.61M |
| Date | Value |
|---|---|
| March 31, 2020 | 21.76M |
| December 31, 2019 | 23.00M |
| September 30, 2019 | 30.02M |
| June 30, 2019 | 28.29M |
| March 31, 2019 | 36.53M |
| December 31, 2018 | 33.33M |
| September 30, 2018 | 30.16M |
| June 30, 2018 | 29.21M |
| March 31, 2018 | 32.89M |
| December 31, 2017 | 34.24M |
| September 30, 2017 | 32.51M |
| June 30, 2017 | 33.13M |
| March 31, 2017 | 26.56M |
| December 31, 2016 | 27.60M |
| September 30, 2016 | 24.42M |
| June 30, 2016 | 32.02M |
| March 31, 2016 | 28.62M |
| December 31, 2015 | 26.17M |
| September 30, 2015 | 19.54M |
| June 30, 2015 | 30.06M |
| March 31, 2015 | 25.97M |
| December 31, 2014 | 26.76M |
| September 30, 2014 | 21.13M |
| June 30, 2014 | 16.74M |
| March 31, 2014 | 21.50M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median